Minyue Chen

Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies

R. Kamm, D. Barbie, Marco Campisi, 2022, Cancers.

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes

Annelisa M Cornel, J. Lieberman, R. Jaenisch, 2022, Nature Cancer.

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.

C. Paweletz, P. Jänne, J. Köhler, 2022, Cancer cell.

The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).

M. Miyagi, Xuan Zhao, H. Kao, 2020, Biochimica et biophysica acta. Molecular cell research.

Activation of tumor-cell STING primes NK-cell therapy.

C. Paweletz, M. Tolstorukov, W. Richards, 2022, Cancer immunology research.

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

P. Lizotte, D. Barbie, D. Dinulescu, 2023, Cancers.

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Henry W. Long, M. Dowsett, Jia-Ren Lin, 2023, Cancer research.